Commentary on the WTO negotiations over waiver of drug patents for Least Developed Countries (LDCs)

Below you will find a collection of articles in the press and commentary by KEI relating to the request for LDC patent exemption on pharmaceutical products at the WTO.

KEI commentary

News reports:

Other NGO commentary:

Governments, Donors:

Industry positions: